Australia markets open in 9 hours 58 minutes

Acerus Pharmaceuticals Corporation (ASP.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
0.36000.0000 (0.00%)
At close: 10:39AM EST
Full screen
Previous close0.3600
Open0.3600
Bid0.3500 x N/A
Ask0.4250 x N/A
Day's range0.3600 - 0.3600
52-week range0.2800 - 10.0000
Volume1,250
Avg. volume1,356
Market cap2.775M
Beta (5Y monthly)1.35
PE ratio (TTM)N/A
EPS (TTM)-4.7180
Earnings date13 Mar 2023 - 17 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Acerus Files For CCAA Protection

    TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced that the Company and its subsidiaries, Acerus Biopharma Inc., Acerus Labs Inc. and Acerus Pharmaceuticals USA, LLC (collectively, the “Acerus Group”), have received an order for creditor protection (the “Initial Order”) from the Ontario Superior Court of Justice (Commercial List) (the “Court”) under the Companies’ Creditors Arrangement Act (the “CCAA”

  • GlobeNewswire

    Acerus Announces Resignation of Director

    TORONTO, Dec. 26, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced that Mr. Scott Leckie has resigned from the board of directors of the Company, effective immediately. About Acerus Acerus Pharmaceuticals Corporation is a specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s heal

  • GlobeNewswire

    Acerus Announces New Loan Agreement With First Generation Capital

    TORONTO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced that it and its wholly-owned subsidiary, Acerus Pharmaceuticals USA, LLC (collectively with the Company, the “Borrowers”), have entered into a US$2 million secured loan agreement (the “Loan Agreement”) with First Generation Capital Inc. (“First Generation”), a company affiliated with the Chairman of the Board of Directors of Acerus.1 Funds under the L